original ) (raw )Clinical significance of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD): potential target for prevention of airway fibrosis and lung cancer
Haydn Walters
Clinical and translational medicine, 2014
View PDFchevron_right
Lung Cancer and Chronic Obstructive Pulmonary Disease: Needs and Opportunities for Integrated Research
Steven Dubinett
JNCI Journal of the National Cancer Institute, 2009
View PDFchevron_right
Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights
Victor Bustamante
Journal of Thoracic Disease, 2016
View PDFchevron_right
The Underappreciated Role of Epithelial Mesenchymal Transition in Chronic Obstructive Pulmonary Disease and Its Strong Link to Lung Cancer
Haydn Walters
Biomolecules, 2021
View PDFchevron_right
Chronic obstructive pulmonary disease and lung cancer
Andrés Varela
Respiratory Medicine: Copd Update, 2009
View PDFchevron_right
Smoking and lung cancer: the role of inflammation
Jane Yanagawa
Proceedings of the American Thoracic Society, 2008
View PDFchevron_right
Concomitant Coronary Artery Disease and Lung Cancer
Wilhelm Mistiaen
Cardiac Surgery, 2020
View PDFchevron_right
Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease
Odd Brustugun
BMC cancer, 2018
View PDFchevron_right
Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation
Alan Kaplan
Prim Care Respir J, 2008
View PDFchevron_right
Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities
Arif Anik
View PDFchevron_right
Epithelial Mesenchymal Plasticity as a Potential Common Link between Lung Disease and Increased Risk of Lung Cancer
Chris Ward
Annals of the American Thoracic Society
View PDFchevron_right
Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke
Javier Milara
Thorax, 2013
View PDFchevron_right
Essential need for rethink of COPD airway pathology: implications for new drug approaches for prevention of lung cancer as well as small airway fibrosis
Haydn Walters
International Journal of Chronic Obstructive Pulmonary Disease, 2017
View PDFchevron_right
Fully integrating pathophysiological insights in COPD: an updated working disease model to broaden therapeutic vision
Haydn Walters
European Respiratory Review, 2021
View PDFchevron_right
COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link
Steven Bozinovski
British Journal of Pharmacology, 2015
View PDFchevron_right
The pathogenesis of COPD and IPF: Distinct horns of the same devil?
Marco Chilosi
Respiratory Research, 2012
View PDFchevron_right
Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease
Sukhwinder Sohal
Expert Review of Respiratory Medicine, 2013
View PDFchevron_right
Comorbidities and their impact on chronic obstructive pulmonary disease
Makbule GEZMEN KARADAĞ
Tuberkuloz ve toraks, 2016
View PDFchevron_right
Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study
Leo Koenderman
Bmj Open, 2013
View PDFchevron_right
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Kian Chung
European Respiratory Journal, 2008
View PDFchevron_right
Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients
Michiyoshi Nishioka
Respiratory research, 2015
View PDFchevron_right
Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Alessandro Marchioni
International Journal of Molecular Sciences
View PDFchevron_right
Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD)
Mark Barger
Respiratory Research, 2013
View PDFchevron_right
Smoking and Pulmonary Fibrosis: Novel Insights
Nikolaos Siafakas
Pulmonary Medicine, 2011
View PDFchevron_right
Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD
Gnanapragasam Arunachalam
Journal of Inflammation, 2010
View PDFchevron_right
Endothelial to mesenchymal transition (EndMT): an active process in Chronic Obstructive Pulmonary Disease (COPD)?
Sangeeta Dey
Respiratory Research, 2016
View PDFchevron_right
The two faces of antioxidants in pulmonary vascular disease: Focus on COPD
Michael Seimetz
View PDFchevron_right
Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapies
Mathew Eapen
Laboratory Investigation, 2019
View PDFchevron_right
Targeting Molecular and Cellular Mechanisms in Chronic Obstructive Pulmonary Disease
A. Nagappa
Targeting Cellular Signalling Pathways in Lung Diseases
View PDFchevron_right
Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease
Samuel Louie
Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2017
View PDFchevron_right
Multimorbidity in elderly patients with chronic obstructive pulmonary disease: stop smoking! Go exercise?
Enrico Clini
American journal of respiratory and critical care medicine, 2014
View PDFchevron_right